Advertisement

European Journal of Pediatrics

, Volume 168, Issue 1, pp 23–25 | Cite as

Presumptive varicella vaccination is warranted in Greek adolescents lacking a history of disease or household exposure

  • Alexandra Katsafadou
  • Konstantina Kallergi
  • George Ferentinos
  • Theodora Goulioti
  • Maria Foustoukou
  • Vassiliki Papaevangelou
Original Paper

Abstract

Current practice favors serotesting adolescents with a negative history of chickenpox rather than offering presumptive vaccination. Recent epidemiologic data from Greece indicate that a high proportion of adolescents (21.5%) are susceptible to chickenpox. We assessed the reliability of negative varicella history in relation to type of exposure in 311 children and 283 adolescents. In children with social or unknown exposure to varicella, a negative history had a high negative predictive value (NPV = 73.5), supporting the clinical practice of presumptive vaccination. Conversely, children with a negative history and household exposure had a low NPV (13.8), suggesting that pre-vaccination serologic testing is warranted. In conclusion, based on our local epidemiologic data, presumptive varicella vaccination should be offered to all adolescents with the exception of the subgroup of adolescents with household exposure.

Keywords

Adolescents History Immunisation Serotesting Vaccine Varicella 

Abbreviations

IgG

Immunoglobulin G

NPV

Negative predictive value

VZV

Viral zoster virus

Notes

Acknowledgements

We would also like to thank Vianex for supporting us financially for the serologic testing.

References

  1. 1.
    Arvin AM (2000) Varicella zoster virus. In: Behrman R, Kliegman. R, Jensen H (eds) Nelson textbook of pediatrics, 15th edn. WB Saunders, Philadelphia, pp 1413–1418Google Scholar
  2. 2.
    Centers of Diseases Control and Prevention (1999) Prevention of varicella: updates recommendations of the Advisory Committee on immunization practices (ACIP). MMWR 48:1–5Google Scholar
  3. 3.
    Choo PW, Donahue JG, Manson JE, Platt R (1995) The epidemiology of varicella and its complications. J Infect Dis 172:706–712PubMedGoogle Scholar
  4. 4.
    Committee on Infectious Diseases, American Academy of Pediatrics (1995) Recommendations for the use of live attenuated varicella vaccine. Pediatrics 95:791–796Google Scholar
  5. 5.
    Coplan P, Coplan P, Black S, Rojas C, Shinefield H, Ray P, Lewis E, Guess H (2001) Incidence and hospitalization rates of varicella and herpes zoster before varicella vaccine introduction: A baseline assessment of the shifting epidemiology of varicella disease. Pediatr Infect Dis J 20:641–645PubMedCrossRefGoogle Scholar
  6. 6.
    Corbeel L (2004) Congenital varicella syndrome, editorial comment. Eur J Pediatr 163:345–346PubMedCrossRefGoogle Scholar
  7. 7.
    Hanslik T, Boelle PY, Schwarzinger M, Carrat F, Freedberg KA, Valleron AJ, Flahault A (2003) Varicella in French adolescents and adults: individual risk assessment and cost-effectiveness of routine vaccination. Vaccine 21:3614–3622PubMedCrossRefGoogle Scholar
  8. 8.
    Harel Z, Ipp L, Riggs S, Vaz R, Flanagan P (2001) Serotesting versus presumptive varicella vaccination of adolescents with a negative or uncertain history of chickenpox. J Adolesc Health 28:26–29PubMedCrossRefGoogle Scholar
  9. 9.
    Heininger U (2002) New immunization recommendations in Germany. Arch Dis Child 86:84CrossRefGoogle Scholar
  10. 10.
    Heininger U, Baer G, Bonhoeffer F, Schaad UB (2005) Reliability of varicella history in children and adolescents. Swiss Med Wkly 135:252–255PubMedGoogle Scholar
  11. 11.
    Holmes CN (2005) Predictive value of a history of varicella infection. Can Fam Physician 51:60–65PubMedGoogle Scholar
  12. 12.
    Jakson MA, Burry VF, Olson LC (1992) Complications of varicella requiring hospitalization in previously healthy children. Pediatr Infect Dis J 11:441–445CrossRefGoogle Scholar
  13. 13.
    Katsafadou A, Ferentinos G, Constantopoulos A, Papaevangelou V (2007) Epidemiology of varicella in school-aged Greek children before the implementation of universal vaccination. Eur J Clin Microbiol Infect Dis. DOI  10.1007/s10096-007-0418-x. Epub 16 Nov 2007
  14. 14.
    Kavaliotis J, Petridou S, Karabaxoglou D (2003) How reliable is the history of chickenpox? Varicella serology among children up to 14 years of age. Int J Infect Dis 7:274–277PubMedCrossRefGoogle Scholar
  15. 15.
    Lieu TA, Finkler LJ, Sorel ME, Black SB, Shinefield HR (1995) Cost-effectiveness of varicella serotesting versus presumptive vaccination of school-age children and adolescents. Pediatrics 95:632–638PubMedGoogle Scholar
  16. 16.
    Lieu TA, Black SB, Takahashi H, Ray P, Capra AM, Shinefield HR, Adler NE (1998) Varicella serology among school age children with a negative or uncertain history of chickenpox. Pediatr Infect Dis J 17:120–125PubMedCrossRefGoogle Scholar
  17. 17.
    Matthew MD, Mitesh SP, Achamyeleh G (2004) Decline in varicella-Related hospitalizations and adults after introduction of varicella vaccine in United States. Pediatrics 114:786–792CrossRefGoogle Scholar
  18. 18.
    Miller E, Marshall R, Vurdien J (1993) Epidemiology, outcome and control of varicella-zoster infection. Rev Med Microbiol 4:222–230Google Scholar
  19. 19.
    Nardone A, de Ory F, Carton M, Cohen D, van Damme P, Davidkin I, Rota MC, de Melker H, Mossong J, Slacikova M, Tischer A, Andrews N, Berbers G, Gabutti G, Gay N, Jones L, Jokinen S, Kafatos G, de Aragón MV, Schneider F, Smetana Z, Vargova B, Vranckx R, Miller E (2007) The comparative sero-epidemiology of varicella-zoster virus in 11 countries in the European region. Vaccine 25:7866–7872PubMedCrossRefGoogle Scholar
  20. 20.
    Nguyen HQ, Jumaan AO, Seward JF (2005) Decline in mortality due to varicella and implementation of varicella vaccination in the United States. N Engl J Med 352:450–458PubMedCrossRefGoogle Scholar
  21. 21.
    Pinot de Moira A, Nardone A, ESEN2 group (2005) Varicella zoster virus vaccination policies and surveillance strategies in Europe. Eurosurveillance 10:3–4Google Scholar
  22. 22.
    Ronan K, Wallace MR (2001) The utility of serologic testing for varicella in an adolescent population. Vaccine 19:4700–4702PubMedCrossRefGoogle Scholar
  23. 23.
    Seward JF (2001) Update on varicella. Pediatr Infect Dis J 20:619–621PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Alexandra Katsafadou
    • 1
  • Konstantina Kallergi
    • 2
  • George Ferentinos
    • 3
  • Theodora Goulioti
    • 2
  • Maria Foustoukou
    • 2
  • Vassiliki Papaevangelou
    • 4
  1. 1.Second Pediatric Clinic“Agia Sophia” Childrens’ HospitalGoudi, AthensGreece
  2. 2.Microbiology Department“A. Kyriakou” Childrens’ HospitalGoudi, AthensGreece
  3. 3.Health Center PsahnaPsahnaGreece
  4. 4.2nd Department of Pediatrics of the University of Athens “A. Kyriakou” Childrens’ HospitalGoudi, AthensGreece

Personalised recommendations